Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
Sequences are standardised representations of biological sequences, typically nucleotide (DNA/RNA) or amino acid (protein) sequences, that are included in patent…
Read More
On 25 September 2025, the EPO’s Enlarged Board of Appeal (‘EBoA’) issued its decision in case G 2/24, the third…
Read More
A Briefing Paper Antibodies and their derivatives, including bispecific and multispecific antibodies, fragments, and fusion products, have become central to…
Read More
The EPO’s Enlarged Board of Appeal (EBA) have issued their decision on G 1/23, providing further clarity to attorneys, patentees and…
Read More
The Unified Patent Court (UPC) allows granted European patents to be enforced or challenged centrally and for a single ruling…
Read More
This article was originally commissioned and published in CITMA’s online blog, May 2025 Thom Browne and Adidas: two global names…
Read More
Anne Bate, patent paralegal & technical workflow specialist, joins John to mark their 30-year working partnership along with managing partner…
Read More
Barker Brettell provides cost-conscious, in-house patent specialists with European expertise Barker Brettell, the UK head-quartered intellectual property (IP) firm, is…
Read More
Applications for registered EU designs can be filed at the EUIPO and offer a convenient, cost-effective way of obtaining design…
Read More
The Enlarged Board of Appeal has issued its preliminary opinion ahead of the upcoming oral proceedings on the G1/24 referral…
Read More
The Unified Patent Court, a centralised court having jurisdiction over infringement and validity of European patents in countries which have…
Read More
The UK Intellectual Property Office (UK IPO) has recently announced the launch of its new ‘One IPO Search’ tool to…
Read More